Device Week, 10 December 2020 – LivaNova Divests Valves; Experts Address ‘Metabesity’
Executive Summary
In this week’s podcast: LivaNova sells its heart valve business to a private equity firm, an expert panel discusses the challenges of addressing so-called “metabesity,” and Dexcom explains its plans to double its revenue over the next few years.
Listen to the podcast via the player below:
Medtech Insight articles addressing topics discussed in this episode: